Using High-Performance Liquid Chromatography to Study Alterations in Biogenic Amines in Drosophila Models of Brain Disorders

Many neuropsychiatric and neurodegenerative disorders are characterized by disruptions in brain neurotransmitters, including alterations in the levels of the biogenic amines (BAs) dopamine (DA) and serotonin (5-hydroxytryptamine; 5-HT), as well as in their release or reuptake. These neurochemical changes correlate with distinct key behavioral phenotypes, such as locomotor deficits, sleep fragmentation, and altered stress responses, among others. Because the principal BA systems interact, disease models frequently show coordinated shifts across multiple amines rather than isolated changes in a single neurotransmitter. Therefore, accurate, simultaneous quantification of several BAs is essential for interpreting behavioral and genetic findings. Drosophila melanogaster offers a genetically tractable system for modeling such disorders and neurotransmitter changes, but BAs occur in fly brain tissue at very low, nanomolar-to-femtomolar concentrations, and the small size of the Drosophila central nervous system makes their detection technically challenging. This study describes a protocol to detect and quantify DA, 5-HT, and octopamine in fly brains using high-performance liquid chromatography coupled with electrochemical detection (HPLC-ECD). HPLC-ECD was applied to detect changes in brain DA and 5-HT in a fly model of Parkinson's disease based on dopaminergic overexpression of human alpha-synuclein. Applying this protocol to the alpha-synuclein Parkinson's disease model reveals significantly elevated dopamine, but unchanged serotonin, relative to controls, consistent with early compensatory dopaminergic mechanisms. This approach provides a sensitive, low-cost, and readily accessible method for multiplexed BA quantification from limited Drosophila tissue. It also enables systematic screening of genetic modifiers and candidate therapeutics targeting monoaminergic pathways relevant to human brain disorders.

Authors

Institutions

Publication Details

Journal
Journal of Visualized Experiments
Published
2026-10-27
DOI
https://doi.org/10.3791/74087
Primary Topic
Neurobiology and Insect Physiology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Using High-Performance Liquid Chromatography to Study Alterations in Biogenic Amines in Drosophila Models of Brain Disorders

Christine A. Tabuloc, Jorge M. Campusano, Sergio Hidalgo, Nathaneal J. Huston et al.
Journal of Visualized Experiments
Neurobiology and Insect Physiology Research
article

Using High-Performance Liquid Chromatography to Study Alterations in Biogenic Amines in Drosophila Models of Brain Disorders

Christine A. Tabuloc, Jorge M. Campusano, Sergio Hidalgo, Nathaneal J. Huston, Pragya Niraj Sharma, Audrey L. Berry, Rafaella V Zárate, Manuel Armendariz
article en

Abstract

Many neuropsychiatric and neurodegenerative disorders are characterized by disruptions in brain neurotransmitters, including alterations in the levels of the biogenic amines (BAs) dopamine (DA) and serotonin (5-hydroxytryptamine; 5-HT), as well as in their release or reuptake. These neurochemical changes correlate with distinct key behavioral phenotypes, such as locomotor deficits, sleep fragmentation, and altered stress responses, among others. Because the principal BA systems interact, disease models frequently show coordinated shifts across multiple amines rather than isolated changes in a single neurotransmitter. Therefore, accurate, simultaneous quantification of several BAs is essential for interpreting behavioral and genetic findings. Drosophila melanogaster offers a genetically tractable system for modeling such disorders and neurotransmitter changes, but BAs occur in fly brain tissue at very low, nanomolar-to-femtomolar concentrations, and the small size of the Drosophila central nervous system makes their detection technically challenging. This study describes a protocol to detect and quantify DA, 5-HT, and octopamine in fly brains using high-performance liquid chromatography coupled with electrochemical detection (HPLC-ECD). HPLC-ECD was applied to detect changes in brain DA and 5-HT in a fly model of Parkinson's disease based on dopaminergic overexpression of human alpha-synuclein. Applying this protocol to the alpha-synuclein Parkinson's disease model reveals significantly elevated dopamine, but unchanged serotonin, relative to controls, consistent with early compensatory dopaminergic mechanisms. This approach provides a sensitive, low-cost, and readily accessible method for multiplexed BA quantification from limited Drosophila tissue. It also enables systematic screening of genetic modifiers and candidate therapeutics targeting monoaminergic pathways relevant to human brain disorders.

Journal of Visualized Experiments(236)
Universidad de Antofagasta (CL), Pontificia Universidad Católica de Chile (CL), University of California System (US), Washington State University (US)
Openalex Percentile: Top 20%
Neurobiology and Insect Physiology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon